Back
The Carlyle Group Vs. Avidity Biosciences Industry Stock Comparison
Buy
73
CG
The Carlyle Group
Last Price:
44.51
Seasonality Move:
0.34%
Sell
31
RNA
Avidity Biosciences
Last Price:
45.67
Seasonality Move:
-1.3%
Buy
73
The Carlyle Group (CG)
is a Buy
Is The Carlyle Group a Buy, Sell or Hold?
- The current The Carlyle Group [CG] share price is $44.51. The Score for CG is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
- CG is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
31
Avidity Biosciences (RNA)
is a Sell
Is Avidity Biosciences a Buy, Sell or Hold?
- The current Avidity Biosciences [RNA] share price is $45.68. The Score for RNA is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
- RNA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CG Stock Price Chart
What is The Carlyle Group's stock price today?
-
The The Carlyle Group share price today is $44.51
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CG is experiencing buying pressure, which is a positive indicator for future bullish movement.
RNA Stock Price Chart
What is Avidity Biosciences's stock price today?
-
The Avidity Biosciences share price today is $45.68
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RNA is experiencing slight buying pressure.
CG Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.22 | Buy |
Relative Strength Index (14 RSI): | 69.3 | Buy |
Chaikin Money Flow: | 1413529 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (38.25 - 41.69) | Buy |
Bollinger Bands (100): | (39.16 - 44.48) | Buy |
RNA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.03 | Buy |
Relative Strength Index (14 RSI): | 62 | Buy |
Chaikin Money Flow: | 402350 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (41.19 - 44.69) | Buy |
Bollinger Bands (100): | (30.3 - 45.36) | Buy |
CG Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 40.53 | Buy |
20-day SMA: | 39.7 | Buy |
50-day SMA: | 42.01 | Buy |
200-day SMA: | 42.43 | Buy |
8-day EMA: | 41.31 | Buy |
20-day EMA: | 40.44 | Buy |
50-day EMA: | 41.03 | Buy |
200-day EMA: | 40.73 | Buy |
RNA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 42.33 | Buy |
20-day SMA: | 42.39 | Buy |
50-day SMA: | 43.82 | Buy |
200-day SMA: | 26.96 | Buy |
8-day EMA: | 43.04 | Buy |
20-day EMA: | 42.7 | Buy |
50-day EMA: | 41.84 | Buy |
200-day EMA: | 30.49 | Buy |
The Carlyle Group Earnings Growth & CG Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.22 per share, an increase next quarter of $0.18 per share, an increase this year of $0.58 per share, and an increase next year of $0.61 per share.
Avidity Biosciences Earnings Growth & RNA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.04 per share, a decrease this year of $0.20 per share, and a decrease next year of $0.17 per share.
The Carlyle Group Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Avidity Biosciences Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |